188 related articles for article (PubMed ID: 34410179)
1. Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.
Tzanetakos D; Tzartos JS; Vakrakou AG; Breza M; Velonakis G; Stathopoulos P; Pantou E; Markakis I; Papadimitriou D; Karavasilis E; Toulas P; Evangelopoulos ΜE; Koutsis G; Anagnostouli M; Stefanis L; Kilidireas C
Mult Scler; 2022 Apr; 28(5):718-729. PubMed ID: 34410179
[TBL] [Abstract][Full Text] [Related]
2. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
Pol S; Schweser F; Bertolino N; Preda M; Sveinsson M; Sudyn M; Babek N; Zivadinov R
Exp Neurol; 2019 Apr; 314():82-90. PubMed ID: 30684521
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images.
Li L; Liu W; Cai Q; Liu Y; Hu W; Zuo Z; Ma Q; He S; Jin K
Front Immunol; 2023; 14():1152235. PubMed ID: 37409120
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
Titelbaum DS; Engisch R; Schwartz ED; Napoli SQ; Sloane JA; Samaan S; Katz JD; Lathi ES
J Neuroimaging; 2020 Nov; 30(6):917-929. PubMed ID: 32830899
[TBL] [Abstract][Full Text] [Related]
5. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
Zurawski J; Tauhid S; Chu R; Khalid F; Healy BC; Weiner HL; Bakshi R
Mult Scler; 2020 Feb; 26(2):177-187. PubMed ID: 31714181
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
Zivadinov R; Ramasamy DP; Hagemeier J; Kolb C; Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Hojnacki D
AJNR Am J Neuroradiol; 2018 Apr; 39(4):642-647. PubMed ID: 29439125
[TBL] [Abstract][Full Text] [Related]
7. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
Ciotti JR; Eby NS; Brier MR; Wu GF; Chahin S; Cross AH; Naismith RT
Mult Scler; 2022 Jan; 28(1):49-60. PubMed ID: 33870786
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
[TBL] [Abstract][Full Text] [Related]
9. MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case report.
Olbert E; Brunner C; Alhani N; Našel C; Struhal W
eNeurologicalSci; 2022 Dec; 29():100432. PubMed ID: 36388768
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Absinta M; Vuolo L; Rao A; Nair G; Sati P; Cortese IC; Ohayon J; Fenton K; Reyes-Mantilla MI; Maric D; Calabresi PA; Butman JA; Pardo CA; Reich DS
Neurology; 2015 Jul; 85(1):18-28. PubMed ID: 25888557
[TBL] [Abstract][Full Text] [Related]
11. Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody.
Xu M; Ma C; Dong M; Guo C; Yang S; Liu Y; Wang X
Front Immunol; 2023; 14():1203615. PubMed ID: 37520572
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
Zivadinov R; Ramasamy DP; Vaneckova M; Gandhi S; Chandra A; Hagemeier J; Bergsland N; Polak P; Benedict RH; Hojnacki D; Weinstock-Guttman B
Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
[TBL] [Abstract][Full Text] [Related]
13. Central Vein Sign in Pediatric Multiple Sclerosis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Harrison KL; Gaudioso C; Levasseur VA; Dunham SR; Schanzer N; Keuchel C; Salter A; Goyal MS; Mar S
Pediatr Neurol; 2023 Sep; 146():21-25. PubMed ID: 37406422
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.
Maranzano J; Dadar M; Rudko DA; De Nigris D; Elliott C; Gati JS; Morrow SA; Menon RS; Collins DL; Arnold DL; Narayanan S
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1162-1169. PubMed ID: 31221631
[TBL] [Abstract][Full Text] [Related]
15. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J
JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547
[TBL] [Abstract][Full Text] [Related]
16. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course.
Abdel-Mannan O; Champsas D; Tur C; Lee V; Manivannan S; Usman H; Skippen A; Desai I; Chitre M; Forsyth R; Kneen R; Ram D; Ramdas S; Rossor T; West S; Wright S; Palace J; Wassmer E; Hemingway C; Lim MJ; Mankad K; Ciccarelli O; Hacohen Y;
J Neurol Neurosurg Psychiatry; 2024 Apr; 95(5):426-433. PubMed ID: 37979966
[TBL] [Abstract][Full Text] [Related]
17. Highly Sensitive 3-Tesla Real Inversion Recovery MRI Detects Leptomeningeal Contrast Enhancement in Chronic Active Multiple Sclerosis.
Okar SV; Dieckhaus H; Beck ES; Gaitán MI; Norato G; Pham DL; Absinta M; Cortese IC; Fletcher A; Jacobson S; Nair G; Reich DS
Invest Radiol; 2024 Mar; 59(3):243-251. PubMed ID: 37493285
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
Bergsland N; Ramasamy D; Tavazzi E; Hojnacki D; Weinstock-Guttman B; Zivadinov R
AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
[TBL] [Abstract][Full Text] [Related]
19. Modified models to distinguish central nervous system demyelinating diseases with brain lesions.
Chen B; Qin C; Ji S; Tian D; Zhang M; Bu B
Mult Scler Relat Disord; 2021 Jul; 52():102965. PubMed ID: 33905981
[TBL] [Abstract][Full Text] [Related]
20. Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum.
Budhram A; Mirian A; Sharma M
Front Neurol; 2022; 13():1044642. PubMed ID: 36341089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]